| FOR RELEASE ON | 04 May 2021 |
IP Group plc - Portfolio company Oxford Nanopore Technologies raises £195m in new investment
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that portfolio company Oxford Nanopore Technologies Ltd ("Oxford Nanopore") has raised £195 million in new capital including £125 million from new investors Temasek, Wellington Management, M&G Investments and Nikon with existing shareholders investing £70 million.
IP Group committed £18.7million to the round, being its full pre-emptive allocation. Following completion of the round, IP Group has a 14.5% undiluted beneficial stake in Oxford Nanopore, valued at £359 million.
For more information, please contact:
| IP Group plc | |
| Greg Smith, Chief Financial Officer | +44 (0) 20 7444 0050 |
| Charlotte Street Partners | |
| David Gaffney | +44 (0) 7854 609998 |
| Andrew Wilson | +44 (0) 7810 636995 |
Notes for editors
About IP Group
IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
Group holdings in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
